Legal & General Group’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-21,252
Closed -$3.82M 3322
2017
Q3
$3.82M Buy
21,252
+3,288
+18% +$591K ﹤0.01% 1204
2017
Q2
$1.87M Buy
17,964
+3,386
+23% +$352K ﹤0.01% 1566
2017
Q1
$1.15M Buy
14,578
+1,080
+8% +$84.8K ﹤0.01% 1742
2016
Q4
$607K Buy
13,498
+4,326
+47% +$195K ﹤0.01% 1925
2016
Q3
$511K Buy
9,172
+149
+2% +$8.3K ﹤0.01% 1685
2016
Q2
$450K Buy
9,023
+1,261
+16% +$62.9K ﹤0.01% 1380
2016
Q1
$355K Buy
7,762
+1,134
+17% +$51.9K ﹤0.01% 1483
2015
Q4
$414K Buy
6,628
+313
+5% +$19.6K ﹤0.01% 1386
2015
Q3
$353K Buy
6,315
+1,812
+40% +$101K ﹤0.01% 1408
2015
Q2
$284K Buy
4,503
+3,094
+220% +$195K ﹤0.01% 1561
2015
Q1
$84K Hold
1,409
﹤0.01% 2157
2014
Q4
$79K Buy
+1,409
New +$79K ﹤0.01% 2149